Thu 20 Aug 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| Inflammatory Regulation Effect of NAC on COVID-19 Treatment | KKUH | Ongoing | N-acetylcysteine | 3 | E-20-4934 | King Khalid University Hospital (Riyadh) |
| Induction Study #1 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn’s Disease. | Celgene | Ongoing | Ozanimod HCl | 3 | RPC01-3201 | KAUH-J |
| Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma | SWOG (Southwest Oncology Group) | Ongoing | Ibrutinib | 3 | A051301 | KFSH&RC-R |
| HELIOS-B: A Phase 3, Randomized, Doubleblind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with Cardiomyopathy) | Alnylam Pharmaceuticals. | Ongoing | ALN-TTRSC02 (Vutrisiran) | 3 | ALN-TTRSC02-003 | King Khalid University Hospital (Riyadh) |
| Global Study to Assess the Addition of Bevacizumab to Carboplatin and Paclitaxel as Front-line Treatment of Epithelial Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Carcinoma | Roche | Completed | Bevacizumab | 3 | MO22923 | KFMC |
| Freeze dried kale to go, new superfood supplement to reduce metabolic risk in Saudi subjects | The National Plan for Science,Technology and Innovation | Ongoing | Freeze dried kale | 3 | H-01-R-002 | King Khalid University Hospital (Riyadh) |
| Follow-up of Phase I/II study of CaspaCIDe T cells (BPX-501) from an HLA-partially matched family donor after negative selection of TCR αβ+T cells in pediatric patients affected by hematological disorders | Bellicum Pharmaceuticals | Ongoing | Rimiducid | 1/2 | CT17-008-R | NGHA-R |
| Fluids in Septic Shock: A Randomized control Trial | McMaster University | Completed | Sodium Chloride | 3 | 20120802 | King Fahad University Hospital (Al-Khobar) |
| Fluids in Septic Shock (FISSH): a randomized controlled trial. | McMaster University | Ongoing | Normal Saline & Ringer's Lactate | 3 | 2211076 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| Extra-corporeal membrane oxygenation plus Tocilizimub in treatment of COVID-19 | KAIMRC | Ongoing | TOCILIZUMAB | 3 | RC20/225/R | King Abdulaziz Medical City NG (Riyadh) |
Last update date: 08/05/2025 at 03:17 PM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.